08.11.2013
- The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...
30.04.2013
- Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies...
24.01.2013
- AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...
18.07.2012
- Abbott Laboratories reported quarterly earnings roughly in line with Wall Street expectations and stuck to its 2012 profit view despite the harsh effects of the stronger dollar, in...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
